{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,9,25]],"date-time":"2026-09-25T10:10:11Z","timestamp":1790331011023,"version":"4.1.0"},"reference-count":57,"publisher":"Elsevier BV","license":[{"start":{"date-parts":[[2026,12,1]],"date-time":"2026-12-01T00:00:00Z","timestamp":1796083200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2026,12,1]],"date-time":"2026-12-01T00:00:00Z","timestamp":1796083200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2026,7,3]],"date-time":"2026-07-03T00:00:00Z","timestamp":1783036800000},"content-version":"vor","delay-in-days":0,"URL":"http:\/\/creativecommons.org\/licenses\/by\/4.0\/"}],"content-domain":{"domain":["elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Toxicology Reports"],"published-print":{"date-parts":[[2026,12]]},"DOI":"10.1016\/j.toxrep.2026.102309","type":"journal-article","created":{"date-parts":[[2026,7,5]],"date-time":"2026-07-05T15:05:34Z","timestamp":1783263934000},"page":"102309","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":0,"special_numbering":"C","title":["Molecular dynamics and predictive toxicity insights into theaflavin as a potential inhibitor of MMP\u22122 and MMP\u22129 in breast cancer"],"prefix":"10.1016","volume":"17","author":[{"given":"Iwan Benny","family":"Purwowidodo","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Farid Sri","family":"Lingganingrum","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Riska","family":"Prasetiawati","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Nining","family":"Juliani","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Taufik Muhammad","family":"Fakih","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Dhania","family":"Novitasari","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ezatul Ezleen","family":"Kamarulzaman","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Muchtaridi","family":"Muchtaridi","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/j.toxrep.2026.102309_bib1","doi-asserted-by":"crossref","DOI":"10.1016\/j.eclinm.2023.102365","article-title":"Feasibility of monitoring global breast cancer initiative framework key performance indicators in 21 Asian national cancer centers alliance member countries","volume":"67","author":"Ong","year":"2024","journal-title":"EClinicalMedicine"},{"issue":"3","key":"10.1016\/j.toxrep.2026.102309_bib2","first-page":"287","article-title":"Global burden of female breast cancer: new estimates in 2022, temporal trend and future projections up to 2050 based on the latest release from GLOBOCAN","volume":"5","author":"Zhang","year":"2025","journal-title":"J. Natl. Cancer Cent."},{"key":"10.1016\/j.toxrep.2026.102309_bib3","doi-asserted-by":"crossref","unstructured":"W. Gautama, Breast Cancer in Indonesia in 2022: 30 Years of Marching in Place, 2022 16(1) (2022) 2.","DOI":"10.33371\/ijoc.v16i1.920"},{"key":"10.1016\/j.toxrep.2026.102309_bib4","first-page":"281","article-title":"Clinical and subtypes of breast cancer in Indonesia","volume":"5","author":"Widiana","year":"2020","journal-title":"Asian Pac. J. Cancer Care"},{"key":"10.1016\/j.toxrep.2026.102309_bib5","doi-asserted-by":"crossref","DOI":"10.1016\/j.aspetd.2025.100012","article-title":"Integrative strategies in breast cancer therapy: conventional approaches, emerging advances, and future challenges","author":"Eapen","year":"2025","journal-title":"ASPET Discov."},{"key":"10.1016\/j.toxrep.2026.102309_bib6","article-title":"Understanding drug resistance in breast cancer: mechanisms and emerging therapeutic strategies","volume":"26","author":"Gautam","year":"2025","journal-title":"Med. Drug. Discov."},{"issue":"12","key":"10.1016\/j.toxrep.2026.102309_bib7","doi-asserted-by":"crossref","DOI":"10.3390\/molecules27123661","article-title":"Signaling pathways and natural compounds in triple-negative breast cancer cell line","volume":"27","author":"Dewi","year":"2022","journal-title":"Molecules"},{"issue":"5","key":"10.1016\/j.toxrep.2026.102309_bib8","doi-asserted-by":"crossref","DOI":"10.3390\/cancers17050787","article-title":"From embryogenesis to senescence: the role of mammary gland physiology in breast cancer risk","volume":"17","author":"Lue","year":"2025","journal-title":"Cancers"},{"issue":"17","key":"10.1016\/j.toxrep.2026.102309_bib9","doi-asserted-by":"crossref","DOI":"10.3390\/cancers13174287","article-title":"Breast cancer-epidemiology, risk factors, classification, prognostic markers, and current treatment strategies-an updated review","volume":"13","author":"\u0141ukasiewicz","year":"2021","journal-title":"Cancers"},{"key":"10.1016\/j.toxrep.2026.102309_bib10","article-title":"Extracellular matrix: emerging roles and potential therapeutic targets for breast cancer","volume":"11","author":"Zhao","year":"2021","journal-title":"Front. Oncol."},{"issue":"5","key":"10.1016\/j.toxrep.2026.102309_bib11","doi-asserted-by":"crossref","DOI":"10.3390\/jcm11051250","article-title":"The role of extracellular matrix proteins in breast cancer","volume":"11","author":"Lepucki","year":"2022","journal-title":"J. Clin. Med."},{"issue":"7","key":"10.1016\/j.toxrep.2026.102309_bib12","doi-asserted-by":"crossref","first-page":"1144","DOI":"10.2741\/4364","article-title":"Matrix metalloproteinases as breast cancer drivers and therapeutic targets","volume":"20","author":"Radisky","year":"2015","journal-title":"Front. Biosci. (Landmark Ed. )"},{"key":"10.1016\/j.toxrep.2026.102309_bib13","article-title":"Matrix metalloproteinases as therapeutic targets in breast cancer","volume":"12","author":"Kwon","year":"2022","journal-title":"Front. Oncol."},{"issue":"1","key":"10.1016\/j.toxrep.2026.102309_bib14","doi-asserted-by":"crossref","first-page":"270","DOI":"10.1038\/s41392-024-01955-5","article-title":"Multi-stage mechanisms of tumor metastasis and therapeutic strategies","volume":"9","author":"Liu","year":"2024","journal-title":"Signal. Transduct. Target. Ther."},{"issue":"6","key":"10.1016\/j.toxrep.2026.102309_bib15","doi-asserted-by":"crossref","first-page":"1827","DOI":"10.31557\/APJCP.2021.22.6.1827","article-title":"CCA-1.1, a novel curcumin analog, exerts cytotoxic anti- migratory activity toward TNBC and HER2-enriched breast cancer cells","volume":"22","author":"Novitasari","year":"2021","journal-title":"Asian Pac. J. Cancer Prev."},{"issue":"2","key":"10.1016\/j.toxrep.2026.102309_bib16","doi-asserted-by":"crossref","first-page":"1153","DOI":"10.1007\/s11033-019-05216-5","article-title":"Clinical significance of plasma MMP-2 and MMP-9 levels as biomarkers for tumor expression in breast cancer patients in Egypt","volume":"47","author":"Alrehaili","year":"2020","journal-title":"Mol. Biol. Rep."},{"key":"10.1016\/j.toxrep.2026.102309_bib17","doi-asserted-by":"crossref","first-page":"4343","DOI":"10.2147\/OTT.S99580","article-title":"Evaluation of MMP-9 and MMP-2 and their suppressor TIMP-1 and TIMP-2 in adenocarcinoma of esophagogastric junction","volume":"9","author":"Lu","year":"2016","journal-title":"Onco Targets Ther."},{"issue":"14","key":"10.1016\/j.toxrep.2026.102309_bib18","doi-asserted-by":"crossref","DOI":"10.3390\/molecules28145567","article-title":"Matrix metalloproteinases inhibitors in cancer treatment: an updated review (2013-2023)","volume":"28","author":"Almutairi","year":"2023","journal-title":"Molecules"},{"issue":"6","key":"10.1016\/j.toxrep.2026.102309_bib19","doi-asserted-by":"crossref","first-page":"509","DOI":"10.1080\/13543776.2021.1881481","article-title":"Novel matrix metalloproteinase inhibitors: an updated patent review (2014 - 2020)","volume":"31","author":"Lenci","year":"2021","journal-title":"Expert. Opin. Ther. Pat."},{"issue":"9","key":"10.1016\/j.toxrep.2026.102309_bib20","doi-asserted-by":"crossref","DOI":"10.1016\/j.jics.2024.101227","article-title":"Identification of naturally occurring flavonoids as anticancer agents: In silico studies","volume":"101","author":"Ali","year":"2024","journal-title":"J. Indian. Chem. Soc."},{"issue":"5","key":"10.1016\/j.toxrep.2026.102309_bib21","doi-asserted-by":"crossref","first-page":"364","DOI":"10.1016\/j.cpt.2025.02.006","article-title":"Phytoconstituents as emerging therapeutics for breast cancer: Mechanistic insights and clinical implications","volume":"3","author":"Devaraji","year":"2025","journal-title":"Cancer Pathog. Ther."},{"issue":"20","key":"10.1016\/j.toxrep.2026.102309_bib22","doi-asserted-by":"crossref","DOI":"10.1016\/j.heliyon.2024.e39229","article-title":"Medicinal plants as a potential resource for the discovery of novel structures towards cancer drug resistance treatment","volume":"10","author":"Nguyen","year":"2024","journal-title":"Heliyon"},{"issue":"6","key":"10.1016\/j.toxrep.2026.102309_bib23","doi-asserted-by":"crossref","first-page":"3485","DOI":"10.1002\/fsn3.3337","article-title":"Isolation and antioxidant characterization of theaflavin for neuroprotective effect in mice model","volume":"11","author":"Ahmad","year":"2023","journal-title":"Food Sci. Nutr."},{"issue":"2","key":"10.1016\/j.toxrep.2026.102309_bib24","doi-asserted-by":"crossref","DOI":"10.3390\/antiox13020207","article-title":"Molecular mechanism of natural food antioxidants to regulate ROS in treating cancer: a review","volume":"13","author":"Muchtaridi","year":"2024","journal-title":"Antioxidants"},{"issue":"9","key":"10.1016\/j.toxrep.2026.102309_bib25","doi-asserted-by":"crossref","DOI":"10.3390\/ijms22094483","article-title":"The interplay between oxidative stress, inflammation and angiogenesis in bladder cancer development","volume":"22","author":"Wigner","year":"2021","journal-title":"Int. J. Mol. Sci."},{"issue":"6","key":"10.1016\/j.toxrep.2026.102309_bib26","doi-asserted-by":"crossref","first-page":"4188","DOI":"10.1039\/D3RA06297J","article-title":"Integration of network pharmacology, molecular docking, and simulations to evaluate phytochemicals from Drymaria cordata against cervical cancer","volume":"14","author":"Bhattacharya","year":"2024","journal-title":"RSC Adv."},{"issue":"5","key":"10.1016\/j.toxrep.2026.102309_bib27","doi-asserted-by":"crossref","first-page":"7225","DOI":"10.3390\/ijms15057225","article-title":"Potential activity of fevicordin-a from Phaleria macrocarpa (Scheff) Boerl. seeds as estrogen receptor antagonist based on cytotoxicity and molecular modelling studies","volume":"15","author":"Muchtaridi","year":"2014","journal-title":"Int. J. Mol. Sci."},{"issue":"1","key":"10.1016\/j.toxrep.2026.102309_bib28","doi-asserted-by":"crossref","first-page":"71","DOI":"10.3390\/pr9010071","article-title":"Molecular dynamics simulations in drug discovery and pharmaceutical development","volume":"9","author":"Salo-Ahen","year":"2021","journal-title":"Processes"},{"issue":"D1","key":"10.1016\/j.toxrep.2026.102309_bib29","doi-asserted-by":"crossref","DOI":"10.1093\/nar\/gkac956","article-title":"PubChem 2023 update","volume":"51","author":"Kim","year":"2023","journal-title":"Nucleic Acids Res."},{"issue":"2","key":"10.1016\/j.toxrep.2026.102309_bib30","doi-asserted-by":"crossref","DOI":"10.3390\/70200206","article-title":"marvin: a platform for chemoinformatics software development","volume":"7","author":"Dominik","year":"2002","journal-title":"Molecules"},{"issue":"2","key":"10.1016\/j.toxrep.2026.102309_bib31","doi-asserted-by":"crossref","first-page":"308","DOI":"10.1021\/ci500405g","article-title":"A virtual screening approach for identifying plants with anti H5N1 neuraminidase activity","volume":"55","author":"Ikram","year":"2015","journal-title":"J. Chem. Inf. Model."},{"issue":"1","key":"10.1016\/j.toxrep.2026.102309_bib32","doi-asserted-by":"crossref","first-page":"822","DOI":"10.1021\/acs.jmedchem.2c01698","article-title":"Discovery of TP0597850: a selective, chemically stable, and slow tight-binding matrix metalloproteinase-2 inhibitor with a phenylbenzamide-pentapeptide hybrid scaffold","volume":"66","author":"Takeuchi","year":"2023","journal-title":"J. Med. Chem."},{"key":"10.1016\/j.toxrep.2026.102309_bib33","doi-asserted-by":"crossref","first-page":"193","DOI":"10.1016\/j.ejmech.2016.01.053","article-title":"Discovery of a new selective inhibitor of A disintegrin and metalloprotease 10 (ADAM-10) able to reduce the shedding of NKG2D ligands in Hodgkin's lymphoma cell models","volume":"111","author":"Camodeca","year":"2016","journal-title":"Eur. J. Med. Chem."},{"issue":"5","key":"10.1016\/j.toxrep.2026.102309_bib34","doi-asserted-by":"crossref","DOI":"10.1371\/journal.pone.0177923","article-title":"Fully automated antibody structure prediction using BIOVIA tools: validation study","volume":"12","author":"Kemmish","year":"2017","journal-title":"PLoS. One"},{"issue":"19","key":"10.1016\/j.toxrep.2026.102309_bib35","doi-asserted-by":"crossref","first-page":"3836","DOI":"10.1093\/bioinformatics\/btz152","article-title":"AutoDock Bias: improving binding mode prediction and virtual screening using known protein-ligand interactions","volume":"35","author":"Arcon","year":"2019","journal-title":"Bioinformatics"},{"key":"10.1016\/j.toxrep.2026.102309_bib36","volume":"2022","author":"Case","year":"2022","journal-title":"Amber"},{"issue":"9","key":"10.1016\/j.toxrep.2026.102309_bib37","doi-asserted-by":"crossref","first-page":"4611","DOI":"10.1021\/acsomega.9b04233","article-title":"Fast, accurate, and reliable protocols for routine calculations of protein-ligand binding affinities in drug design projects using AMBER GPU-TI with ff14SB\/GAFF","volume":"5","author":"He","year":"2020","journal-title":"ACS Omega"},{"issue":"8","key":"10.1016\/j.toxrep.2026.102309_bib38","doi-asserted-by":"crossref","DOI":"10.1371\/journal.pone.0042846","article-title":"An efficient computational method for calculating ligand binding affinities","volume":"7","author":"Suenaga","year":"2012","journal-title":"PLOS One"},{"issue":"1","key":"10.1016\/j.toxrep.2026.102309_bib39","doi-asserted-by":"crossref","first-page":"42717","DOI":"10.1038\/srep42717","article-title":"SwissADME: a free web tool to evaluate pharmacokinetics, drug-likeness and medicinal chemistry friendliness of small molecules","volume":"7","author":"Daina","year":"2017","journal-title":"Sci. Rep."},{"issue":"W1","key":"10.1016\/j.toxrep.2026.102309_bib40","doi-asserted-by":"crossref","first-page":"W257","DOI":"10.1093\/nar\/gky318","article-title":"ProTox-II: a webserver for the prediction of toxicity of chemicals","volume":"46","author":"Banerjee","year":"2018","journal-title":"Nucleic Acids Res."},{"key":"10.1016\/j.toxrep.2026.102309_bib41","doi-asserted-by":"crossref","first-page":"498","DOI":"10.1016\/j.ymeth.2022.02.004","article-title":"Drug repurposing for identification of potential spike inhibitors for SARS-CoV-2 using molecular docking and molecular dynamics simulations","volume":"203","author":"Lazniewski","year":"2022","journal-title":"Methods"},{"issue":"5","key":"10.1016\/j.toxrep.2026.102309_bib42","doi-asserted-by":"crossref","DOI":"10.3390\/biom15050706","article-title":"Discovery and characterisation of novel poly-histidine-poly-glycine peptides as matrix metalloproteinase inhibitors","volume":"15","author":"Wang","year":"2025","journal-title":"Biomolecules"},{"key":"10.1016\/j.toxrep.2026.102309_bib43","doi-asserted-by":"crossref","first-page":"146","DOI":"10.1016\/j.jinorgbio.2011.10.018","article-title":"Secondary interactions involving zinc-bound ligands: roles in structural stabilization and macromolecular interactions","volume":"111","author":"Namuswe","year":"2012","journal-title":"J. Inorg. Biochem."},{"issue":"6","key":"10.1016\/j.toxrep.2026.102309_bib44","doi-asserted-by":"crossref","DOI":"10.3390\/molecules26061776","article-title":"Aromatic rings as molecular determinants for the molecular recognition of protein kinase inhibitors","volume":"26","author":"Zhu","year":"2021","journal-title":"Molecules"},{"issue":"1","key":"10.1016\/j.toxrep.2026.102309_bib45","doi-asserted-by":"crossref","first-page":"35","DOI":"10.3390\/biom15010035","article-title":"Targeting invasion: the role of MMP-2 and MMP-9 inhibition in colorectal cancer therapy","volume":"15","author":"Shoari","year":"2025","journal-title":"Biomolecules"},{"key":"10.1016\/j.toxrep.2026.102309_bib46","doi-asserted-by":"crossref","DOI":"10.1016\/j.foodchem.2020.128933","article-title":"An in-silico evaluation of different bioactive molecules of tea for their inhibition potency against non structural protein-15 of SARS-CoV-2","volume":"346","author":"Sharma","year":"2021","journal-title":"Food Chem."},{"issue":"3","key":"10.1016\/j.toxrep.2026.102309_bib47","doi-asserted-by":"crossref","first-page":"598","DOI":"10.1016\/j.tiv.2007.11.021","article-title":"Theaflavin-3,3\u2032-digallate, a component of black tea: an inducer of oxidative stress and apoptosis","volume":"22","author":"Schuck","year":"2008","journal-title":"Toxicol. Vitr."},{"issue":"9","key":"10.1016\/j.toxrep.2026.102309_bib48","doi-asserted-by":"crossref","first-page":"3378","DOI":"10.1021\/jf0633342","article-title":"Breast cancer prevention by green tea catechins and black tea theaflavins in the C3(1) SV40 T,t antigen transgenic mouse model is accompanied by increased apoptosis and a decrease in oxidative DNA adducts","volume":"55","author":"Kaur","year":"2007","journal-title":"J. Agric. Food Chem."},{"issue":"22","key":"10.1016\/j.toxrep.2026.102309_bib49","first-page":"6190","article-title":"Identification of a basal promoter for the human Mr 72,000 type IV collagenase gene and enhanced expression in a highly metastatic cell line","volume":"51","author":"Templeton","year":"1991","journal-title":"Cancer Res."},{"key":"10.1016\/j.toxrep.2026.102309_bib50","doi-asserted-by":"crossref","DOI":"10.1016\/j.ejmech.2025.117669","article-title":"Synthetic flavonoid dimers: Synthesis strategies and biological activities","volume":"291","author":"Pereira","year":"2025","journal-title":"Eur. J. Med. Chem."},{"issue":"1","key":"10.1016\/j.toxrep.2026.102309_bib51","doi-asserted-by":"crossref","first-page":"235","DOI":"10.1002\/med.21985","article-title":"The entrancing role of dietary polyphenols against the most frequent aging-associated diseases","volume":"44","author":"Shah","year":"2024","journal-title":"Med. Res. Rev."},{"issue":"2","key":"10.1016\/j.toxrep.2026.102309_bib52","doi-asserted-by":"crossref","first-page":"703","DOI":"10.1039\/C8FO02013B","article-title":"Luteolin inhibits proliferation and induces apoptosis of human melanoma cells in vivo and in vitro by suppressing MMP-2 and MMP-9 through the PI3K\/AKT pathway","volume":"10","author":"Yao","year":"2019","journal-title":"Food Funct."},{"key":"10.1016\/j.toxrep.2026.102309_bib53","doi-asserted-by":"crossref","first-page":"272","DOI":"10.1016\/j.biopha.2018.04.014","article-title":"Hispidulin inhibits hepatocellular carcinoma growth and metastasis through AMPK and ERK signaling mediated activation of PPAR\u03b3","volume":"103","author":"Han","year":"2018","journal-title":"Biomed. Pharmacother."},{"issue":"2","key":"10.1016\/j.toxrep.2026.102309_bib54","doi-asserted-by":"crossref","DOI":"10.3390\/molecules23020384","article-title":"Wogonin suppresses the activity of matrix metalloproteinase-9 and inhibits migration and invasion in human hepatocellular carcinoma","volume":"23","author":"Hong","year":"2018","journal-title":"Molecules"},{"issue":"14","key":"10.1016\/j.toxrep.2026.102309_bib55","doi-asserted-by":"crossref","first-page":"2165","DOI":"10.1016\/j.ejca.2004.06.018","article-title":"Black tea polyphenol theaflavins inhibit aromatase activity and attenuate tamoxifen resistance in HER2\/neu-transfected human breast cancer cells through tyrosine kinase suppression","volume":"40","author":"Way","year":"2004","journal-title":"Eur. J. Cancer"},{"key":"10.1016\/j.toxrep.2026.102309_bib56","article-title":"Screening, docking, and molecular dynamics analysis of Mitragyna speciosa (Korth.) compounds for targeting HER2 in breast cancer","volume":"10","author":"Akbar","year":"2025","journal-title":"Curr. Res. Struct. Biol."},{"key":"10.1016\/j.toxrep.2026.102309_bib57","doi-asserted-by":"crossref","first-page":"4188","DOI":"10.1039\/D3RA06297J","article-title":"Integration of network pharmacology, molecular docking, and simulations to evaluate phytochemicals from Drymaria cordata against cervical cancer","volume":"14","author":"Bhattacharya","year":"2024","journal-title":"RSC Adv."}],"container-title":["Toxicology Reports"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S2214750026001113?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S2214750026001113?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2026,9,25]],"date-time":"2026-09-25T09:51:39Z","timestamp":1790329899000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S2214750026001113"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2026,12]]},"references-count":57,"alternative-id":["S2214750026001113"],"URL":"https:\/\/doi.org\/10.1016\/j.toxrep.2026.102309","relation":{},"ISSN":["2214-7500"],"issn-type":[{"value":"2214-7500","type":"print"}],"subject":[],"published":{"date-parts":[[2026,12]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Molecular dynamics and predictive toxicity insights into theaflavin as a potential inhibitor of MMP\u22122 and MMP\u22129 in breast cancer","name":"articletitle","label":"Article Title"},{"value":"Toxicology Reports","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.toxrep.2026.102309","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2026 The Author(s). Published by Elsevier B.V.","name":"copyright","label":"Copyright"}],"article-number":"102309"}}